Actualités XOMA Royalty Corporation - XOMA | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2023-05-09 2023-05-09 0000791908 us-gaap:CommonStockMember 2023-05-09 2023-05-09 0000791908...

XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy

First quarter with incoming cashflows from two commercial assets Completed first royalty asset acquisition...

XOMA to Present at H.C. Wainwright BioConnect Investor Conference

EMERYVILLE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty...

Proxy Statement (definitive) (def 14a)

DEF 14Afalse0000791908 0000791908 2022-01-01 2022-12-31 0000791908 2021-01-01 2021-12-31 0000791908...

XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio

EMERYVILLE, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the...

Annual Report (10-k)

00007919082022FYfalseNoNoYesYes0.020.0010.539060.523440.539060.523440.539060.523440.539060.523440.539060.523440P1Y0000791908xoma:AronoraIncMemberxo...

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2023-03-09 2023-03-09 0000791908 us-gaap:CommonStockMember 2023-03-09 2023-03-09 0000791908...

XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy

2022 was the first year with cash receipts from a commercial asset since becoming a royalty aggregator...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

XOMA Royalty Corporation (XOMA)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

XOMA Actualités

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy

XOMA to Present at H.C. Wainwright BioConnect Investor Conference

Proxy Statement (definitive) (def 14a)

XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio

XOMA Declares Quarterly Preferred Stock Dividends

Annual Report (10-k)

Current Report Filing (8-k)

XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy

XOMA to Present at 43rd Annual Cowen Health Care Conference

Amended Statement of Ownership (sc 13g/a)

Securities Registration: Employee Benefit Plan (s-8)

Statement of Changes in Beneficial Ownership (4)

XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

XOMA Royalty Corporation (XOMA) Actualités

XOMA Royalty Corporation (XOMA)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

XOMA Actualités

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy

XOMA to Present at H.C. Wainwright BioConnect Investor Conference

Proxy Statement (definitive) (def 14a)

XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio

XOMA Declares Quarterly Preferred Stock Dividends

Annual Report (10-k)

Current Report Filing (8-k)

XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy

XOMA to Present at 43rd Annual Cowen Health Care Conference

Amended Statement of Ownership (sc 13g/a)

Securities Registration: Employee Benefit Plan (s-8)

Statement of Changes in Beneficial Ownership (4)

XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application